Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUSD499802 S1
Publication typeGrant
Application numberUS 29/178,877
Publication dateDec 14, 2004
Filing dateApr 1, 2003
Priority dateApr 1, 2003
Publication number178877, 29178877, US D499802 S1, US D499802S1, US-S1-D499802, USD499802 S1, USD499802S1
InventorsJohn Pinon, Sameer Shirgaonkar, Christopher James Smith, Simon Burge, Max William Middleton, David Ahern, Matthew Neil Sarkar, Ben Arlett, Emma Lesley Lye, Simon Smith
Original AssigneeChiesi Farmaceutici S.P.A.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Powder inhaler
US D499802 S1
Abstract  available in
Images(7)
Previous page
Next page
Claims(1)
  1. The ornamental design for a powder inhaler, as shown and described.
Description

FIG. 1 is a side perspective view of a powder inhaler showing our new design, with the cover shown in closed position;

FIG. 2 is a s side perspective view of the powder inhaler shown in FIG. 1 with the cover being disposed in an open position;

FIG. 3 is an elevated right side view of the powder inhaler shown in FIG. 1;

FIG. 4 is an elevated back side view of the powder inhaler shown in FIG. 1;

FIG. 5 is an elevated left side view of the powder inhaler shown in FIG. 2;

FIG. 6 is a top perspective view of the powder inhaler shown in FIG. 2;

FIG. 7 is a top perspective view of a second embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a violet color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 8 is a side perspective view of the powder inhaler shown in FIG. 7 with the cover being disposed in an open position;

FIG. 9 is an elevated right side view of the powder inhaler shown in FIG. 7;

FIG. 10 is an elevated back side view of the powder inhaler shown in FIG. 7;

FIG. 11 is an elevated left side view of the powder inhaler shown in FIG. 8;

FIG. 12 is a top perspective view of the powder inhaler shown in FIG. 8;

FIG. 13 is a top perspective view of a third embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has an orange color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 14 is a side perspective view of the powder inhaler shown in FIG. 13 with the cover being disposed in an open position;

FIG. 15 is an elevated right side view of the powder inhaler shown in FIG. 13;

FIG. 16 is an elevated back side view of the powder inhaler shown in FIG. 13;

FIG. 17 is an elevated left side view of the powder inhaler shown in FIG. 14;

FIG. 18 is a top perspective view of the powder inhaler shown in FIG. 14;

FIG. 19 is a top perspective view of a fourth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a green color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 20 is a side perspective view of the powder inhaler shown in FIG. 19 with the cover being disposed in an open position;

FIG. 21 is an elevated right side view of the powder inhaler shown in FIG. 19;

FIG. 22 is an elevated back side view of the powder inhaler shown in FIG. 19;

FIG. 23 is an elevated left side view of the powder inhaler shown in FIG. 20;

FIG. 24 is a top perspective view of the powder inhaler shown in FIG. 20;

FIG. 25 is a top perspective view of a fifth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a burgundy color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 26 is a side perspective view of the powder inhaler shown in FIG. 25 with the cover being disposed in an open position;

FIG. 27 is an elevated right side view of the powder inhaler shown in FIG. 25;

FIG. 28 is an elevated back side view of the powder inhaler shown in FIG. 25;

FIG. 29 is an elevated left side view of the powder inhaler shown in FIG. 26;

FIG. 30 is a top perspective view of the powder inhaler shown in FIG. 26;

FIG. 31 is a top perspective view of a sixth embodiment of the powder inhaler shown in FIG. 1, the only difference being that the cover has a blue color, it being understood that all other surfaces are the same as those of the first embodiment;

FIG. 32 is a side perspective view of the powder inhaler shown in FIG. 31 with the cover being disposed in an open position;

FIG. 33 is an elevated right side view of the powder inhaler shown in FIG. 31;

FIG. 34 is an elevated back side view of the powder inhaler shown in FIG. 31;

FIG. 35 is an elevated left side view of the powder inhaler shown in FIG. 32; and,

FIG. 36 is a top perspective view of the powder inhaler shown in FIG. 32.

Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US8424518Jun 12, 2009Apr 23, 2013Mannkind CorporationDry powder inhaler and system for drug delivery
US8485180Mar 4, 2010Jul 16, 2013Mannkind CorporationDry powder drug delivery system
US8499757Jun 12, 2009Aug 6, 2013Mannkind CorporationDry powder inhaler and system for drug delivery
US8636001Jun 12, 2009Jan 28, 2014Mannkind CorporationDry powder inhaler and system for drug delivery
US8912193Jun 18, 2013Dec 16, 2014Mannkind CorporationDry powder inhaler and system for drug delivery
US9192675Jul 30, 2013Nov 24, 2015Mankind CorporationDry powder inhaler and system for drug delivery
US9220687Nov 7, 2014Dec 29, 2015Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9233159Oct 24, 2012Jan 12, 2016Mannkind CorporationMethods and compositions for treating pain
US9241903Jul 15, 2013Jan 26, 2016Mannkind CorporationMethod for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193Apr 10, 2014Mar 15, 2016Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9339615Mar 14, 2013May 17, 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US9358352Jun 21, 2011Jun 7, 2016Mannkind CorporationDry powder drug delivery system and methods
US9364436Jun 18, 2012Jun 14, 2016Mannkind CorporationHigh capacity diketopiperazine microparticles and methods
US9364619Jun 19, 2009Jun 14, 2016Mannkind CorporationInteractive apparatus and method for real-time profiling of inhalation efforts
US9393372Jul 2, 2013Jul 19, 2016Mannkind CorporationDry powder drug delivery system
US9446001Jun 22, 2015Sep 20, 2016Mannkind CorporationIncreasing drug affinity for crystalline microparticle surfaces
US9446133Oct 21, 2014Sep 20, 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US9511198Nov 27, 2013Dec 6, 2016Mannkind CorporationDry powder inhaler and system for drug delivery
US9610351Feb 13, 2015Apr 4, 2017Mannkind CorporationMethods and compositions for treating pain
US9630930Apr 11, 2014Apr 25, 2017Mannkind CorporationDiketopiperazine microparticles with defined specific surface areas
US9655850Nov 18, 2015May 23, 2017Mannkind CorporationSubstituted diketopiperazine analogs for use as drug delivery agents
US9662461May 2, 2016May 30, 2017Mannkind CorporationDry powder drug delivery system and methods
US9675674Jan 8, 2016Jun 13, 2017Mannkind CorporationDiketopiperazine salts for drug delivery and related methods
US9700690Jun 12, 2014Jul 11, 2017Mannkind CorporationInhalation apparatus
US9706944Mar 24, 2015Jul 18, 2017Mannkind CorporationApparatus and method for simulating inhalation efforts
US9717689Feb 5, 2016Aug 1, 2017Mannkind CorporationMethod of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
USD669791May 19, 2011Oct 30, 2012R.J. Reynolds Tobacco CompanySpray dispensing container
USD669792Mar 10, 2011Oct 30, 2012R.J. Reynolds Tobacco CompanySpray dispensing container
USD745660 *Jun 25, 2014Dec 15, 2015Oriel Therapeutics, Inc.Dry powder inhaler
Classifications
U.S. ClassificationD24/110